Serum glucose and insulin and risk of cancers of the breast, endometrium, and ovary in postmenopausal women.

Publication Date

2018

Journal Title

Eur J Cancer Prev

Abstract

Limited evidence suggests that hyperinsulinemia may contribute to the risk of breast, endometrial, and, possibly, ovarian cancer. The aim of this study was to assess the association of serum glucose and insulin with risk of these cancers in postmenopausal women, while taking into account potential confounding and modifying factors. We studied 21 103 women with fasting baseline insulin and glucose measurements in a subsample of the Women's Health Initiative. The subsample was composed of four studies within Women's Health Initiative with different selection and sampling strategies. Over a mean of 14.7 years of follow-up, 1185 breast cancer cases, 156 endometrial cancer cases, and 130 ovarian cancer cases were diagnosed. We used Cox proportional hazards models to estimate hazard ratios (HRs) and 95% confidence intervals (95% CIs) by quartile of glucose or insulin. Serum insulin was positively associated with breast cancer risk (multivariable-adjusted HR for highest vs. lowest quartile 1.41, 95% CI: 1.16-1.72, Ptrend

Volume Number

27

Issue Number

3

Pages

261-268

Document Type

Article

Status

Faculty

Facility

School of Medicine

Primary Department

Occupational Medicine, Epidemiology, and Prevention

PMID

29438162

DOI

10.1097/CEJ.0000000000000435

For the public and Northwell Health campuses

Share

COinS